Although cannabinoids have shown promise for epilepsy in general, Epidiolex is only approved for two kinds of childhood epilepsy. But this may be more a reflection of the FDA’s drug approval process than of the conditions for which CBD helps.

Doctors at the Cleveland Clinic Foundation recently examined how cannabis users faired through pancreatitis compared to the general population. They surveyed records of 2.8 million acute pancreatitis patients over 10 years, and the results were dramatic.

How do cannabinoids affect memory and learning? It seems like a simple question, but scientists study its answer in complex ways. The kind of memory in question, the species tested, the animals’ age and sex, and so on, all affect the answer. So, scientists at Kings College in London compiled 195 articles on cannabinoids and memory for review. ⁠

Without dedicated attention to those most harmed by police enforcement of drug laws, their situation might not improve. A new study highlights how youth have been left behind because legalization often does not reduce penalties for underage possession.

A third of patients still do not find effective methods for preventing seizures. A recent Canadian study has demonstrated synergy between the anti-seizure activity of THC and CBD.

Scientists in Australia and New Zealand recently examined how a synthetic cannabinoid, CUMYL-4CN-BINACA, causes seizures.

An Israeli observational study of 367 people using cannabis for fibromyalgia shows promising results. Many subjects reported significant decreases in pain and increases in quality of life.

Bipolar disorder is rarely considered from our growing perspective of the endocannabinoid system in mental health. Iranian researchers at Kerman University recently reviewed the beneficial and harmful aspects of endocannabinoids in this disease.

California researchers tried to threaten and belittle middle-schoolers into fearing cannabis. Not only does the tactic not work, and it can increase chances of risky behavior to more dangerous drugs.

Dr. Donald Abrams laid out the potential of cannabis in cancer care in a recent piece titled “Should Oncologists recommend cannabis?”